For the clinic-pathological correlation analysis, 1086 breast cancer patients within TCGA were divided into two groups: high MALAT1 group (n=169) and low MALAT1 group (n=917) by adopting the gene-specific threshold of MALAT1 expression in breast cancer tissues as a cut-off value. This evidence concerns the gene MALAT1 and breast carcinoma.